Jump to Content
HOME BROWSE
CLINICAL RESOURCES DRUG INFORMATION EDUCATION AND TRAINING PHARMACY PRACTICE CAREER DEVELOPMENT
AJHP DRUG INFORMATION PROFESSIONAL DEVELOPMENT
Sign in Sign up
Advanced Search Help

ASHP Logo

Sign in Sign up
HOME BROWSE
CLINICAL RESOURCES DRUG INFORMATION EDUCATION AND TRAINING PHARMACY PRACTICE CAREER DEVELOPMENT
AJHP DRUG INFORMATION PROFESSIONAL DEVELOPMENT
Advanced Search Help

Cover Clinical Pharmacokinetics
 

 

Front Matter
Preliminary Material
Basic Concepts and Special Populations
RATIONAL USE OF DRUG CONCENTRATION MEASUREMENTS
ASSESSMENT OF KIDNEY FUNCTION
RENAL DRUG DOSING CONCEPTS
MEDICATION DOSING IN OVERWEIGHT AND OBESE PATIENTS
PHARMACOGENOMIC IMPACTS ON PHARMACOKINETICS
DRUG DOSING IN PEDIATRIC PATIENTS
CONSIDERATIONS FOR MEDICATION USE IN THE GERIATRIC PATIENT
Specific Drugs and Drug Classes
AMINOGLYCOSIDES
ANTIDEPRESSANTS
ANTIEPILEPTICS
ANTIREJECTION AGENTS
CARBAMAZEPINE
DIGOXIN
ETHOSUXIMIDE
UNFRACTIONATED HEPARIN, LOW-MOLECULAR-WEIGHT HEPARINS, AND FONDAPARINUX
LIDOCAINE
LITHIUM
PHENOBARBITAL
PHENYTOIN AND FOSPHENYTOIN
THEOPHYLLINE
VALPROATE
VANCOMYCIN
WARFARIN
APPENDICES
APPENDIX A
APPENDIX B
Back Matter
Index

LITHIUM

in Clinical Pharmacokinetics
Authors:
Tanya J. Fabian
and
Matthew A. Fuller
DOI:
https://doi.org/10.37573/9781585286607.017
Restricted access
Email this content

Share Link


Copy this link, or click below to email it to a friend
Email this content
or copy the link directly:
The link was not copied. Your current browser may not support copying via this button.
Link copied successfully

ASHP Logo

About ASHP Contact Us Customer Relations
FAQs Information for Authors Libraries and Institutions

© 2024 American Society of Health-System Pharmacists. All Rights Reserved.

Powered by: PubFactory

Powered by PubFactory
  • [18.97.14.90]
  • 18.97.14.90
Close
Edit

Character limit 500/500

@!

Character limit 500/500